Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.

Bibliographic Details
Title: Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.
Authors: Fahey, Catherine C., Nebhan, Caroline A., York, Sally, Davis, Nancy B., Hurley, Paula J., Gordetsky, Jennifer B., Schaffer, Kerry R.
Source: International Journal of Molecular Sciences; Nov2023, Vol. 24 Issue 22, p16109, 8p
Subject Terms: SQUAMOUS cell carcinoma, PENILE cancer, ANTIBODY-drug conjugates, PROGRESSION-free survival, METASTASIS, RARE diseases
Abstract: Penile squamous cell carcinoma is a rare disease with very limited data to guide treatment decisions. In particular, there is minimal evidence for effective therapies in the metastatic setting. Here, we present a case of metastatic penile squamous cell carcinoma with response to the Nectin-4 inhibitor enfortumab-vedotin-ejfv (EV). EV was selected due to the evidence of the high expression of Nectin-4 in squamous cell carcinomas, including penile carcinoma. The patient had both radiographic and symptomatic improvement after two cycles of treatment, despite having been treated with multiple prior lines of traditional chemotherapy. This case provides support for the use of antibody–drug conjugates (ADC), including EV, in this disease with few other options in the advanced setting. Further studies examining Nectin-4 and ADCs in penile squamous cell carcinoma should be completed, as high-quality evidence is needed to guide treatment after initial progression for these patients. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Full text is not displayed to guests.
More Details
ISSN:16616596
DOI:10.3390/ijms242216109
Published in:International Journal of Molecular Sciences
Language:English